Lymphadenopathy historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lymphadenopathy}} | {{Lymphadenopathy}} | ||
{{CMG}}{{AE}}{{ADS}} | {{CMG}}, {{AE}}{{ADS}} | ||
==Overview== | ==Overview== | ||
There is limited information about the historical perspective of lymphadenopathy. | There is limited information about the historical perspective of lymphadenopathy. | ||
| Line 12: | Line 12: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Inflammations]] | |||
[[Category:Dermatology]] | |||
[[Category:Medical signs]] | |||
[[Category:Signs and symptoms]] | |||
{{ | [[Category:Physical examination]] | ||
{{ | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hematology]] | |||
Latest revision as of 15:07, 7 February 2019
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy historical perspective On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy historical perspective |
|
Risk calculators and risk factors for Lymphadenopathy historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
There is limited information about the historical perspective of lymphadenopathy.
Historical Perspective
Discovery
- There is limited information about the historical perspective of lymphadenopathy.